Risk Factors of In-Hospital Mortality of Intracerebral Hemorrhage and Comparison of ICH Scores in a Taiwanese PopulationChen H.-S.a · Hsieh C.-F.b · Chau T.-T.c · Yang C.-D.d · Chen Y.-W.e, f
aDivision of Infection, Department of Medicine, bResearch Center, cDepartment of Family Medicine, dDivision of Neurosurgery, Department of Surgery, and eDepartment of Neurology, Landseed Hospital, Taoyuan, and fDepartment of Neurology, National Taiwan University Hospital, Taipei, Taiwan, ROC
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background and Purpose: Intracerebral hemorrhage (ICH) is associated with substantial morbidity and mortality. This study aimed to explore the risk factors associated with mortality and unfavorable outcome of ICH in Taiwan and to compare the predictive power with the existing ICH scores. Methods: Medical records of the ICH patients consecutively admitted to a regional hospital between January 2003 and December 2006 were reviewed retrospectively. The demographics, outcome, clinical and radiological characteristics were also analyzed. Results: A total of 61 among 285 (21.4%) ICH patients died during hospitalization. Diabetes mellitus, lower scores of initial Glasgow Coma Scale, initial ICH volume >30 ml, and intraventricular hematoma were identified as major independent risk factors associated with in-hospital mortality in the logistic regression model. In comparison to the predictive power for mortality and unfavorable outcome, Barthel Index <40 at discharge, the results showed no significant difference among the scores derived from our study, the ICH score by Hemphill and the modified ICH score developed in Taiwan. Conclusions: Although these ICH scores developed with various measurements, no significant difference in predicting mortality and unfavorable functional outcomes was found. The results supporting the ICH score by Hemphill may provide a good prediction in acute outcome across ethnic groups.
© 2011 S. Karger AG, Basel
- Lovelock CE, Molyneux AJ, Rothwell PM: Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007;6:487–493.
- Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF: Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344:1450–1460.
- Hsieh FI, Lien LM, Chen ST, Bai CH, Sun MC, Tseng HP, Chen YW, Chen CH, Jeng JS, Tsai SY, Lin HJ, Liu CH, Lo YK, Chen HJ, Chiu HC, Lai ML, Lin RT, Sun MH, Yip BS, Chiou HY, Hsu CY: Get with the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: get with the Guidelines-Stroke in Taiwan. Circulation 2010;122:1116–1123.
- Van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ: Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010;9:167–176.
- Rost NS, Smith EE, Chang Y, Snider RW, Chanderraj R, Schwab K, FitzMaurice E, Wendell L, Goldstein JN, Greenberg SM, Rosand J: Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 2008;39:2304–2309.
- Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC: The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891–897.
- Kusano Y, Seguchi T, Horiuchi T, Kakizawa Y, Kobayashi T, Tanaka Y, Seguchi K, Hongo K: Prediction of functional outcome in acute cerebral hemorrhage using diffusion tensor imaging at 3T: a prospective study. AJNR Am J Neuroradiol 2009;30:1561–1565.
- Delgado P, Alvarez-Sabin J, Abilleira S, Santamarina E, Purroy F, Arenillas JF, Molina CA, Fernandez-Cadenas I, Rosell A, Montaner J: Plasma D-dimer predicts poor outcome after acute intracerebral hemorrhage. Neurology 2006;67:94–98.
- Hemphill JC 3rd, Farrant M, Neill TA Jr: Prospective validation of the ICH score for 12-month functional outcome. Neurology 2009;73:1088–1094.
- Cheung RT, Zou LY: Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke 2003;34:1717–1722.
- Cho DY, Chen CC, Lee WY, Lee HC, Ho LH: A new modified intracerebral hemorrhage score for treatment decisions in basal ganglia hemorrhage – a randomized trial. Crit Care Med 2008;36:2151–2156.
Lindenstrøm E BG, Waage Christiansen L, à Rogvi Hansen B, Nielsen PW: Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis 1991;1:103–107.
- Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J: The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304–1305.
- De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P: A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke 1993;24:1178–1181.
- Qureshi AI, Mendelow AD, Hanley DF: Intracerebral haemorrhage. Lancet 2009;373:1632–1644.
- Delgado Almandoz JE, Yoo AJ, Stone MJ, Schaefer PW, Oleinik A, Brouwers HB, Goldstein JN, Rosand J, Lev MH, Gonzalez RG, Romero JM: The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke 2010;41:54–60.
- Arboix A, Massons J, Garcia-Eroles L, Oliveres M, Targa C: Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care 2000;23:1527–1532.
- Sacco S, Marini C, Toni D, Olivieri L, Carolei A: Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 2009;40:394–399.
- Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE: Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 2009;72:1397–1402.
- Qureshi AI, Harris-Lane P, Kirmani JF, Ahmed S, Jacob M, Zada Y, Divani AA: Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med 2006;34:1975–1980.
- Weimar C, Benemann J, Diener HC: Development and validation of the Essen intracerebral haemorrhage score. J Neurol Neurosurg Psychiatry 2006;77:601–605.
- Ruiz-Sandoval JL, Romero-Vargas S, Chiquete E, Padilla-Martinez JJ, Villarreal-Careaga J, Cantu C, Arauz A, Barinagarrementeria F: Hypertensive intracerebral hemorrhage in young people: previously unnoticed age-related clinical differences. Stroke 2006;37:2946–2950.
- Thompson BB, Bejot Y, Caso V, Castillo J, Christensen H, Flaherty ML, Foerch C, Ghandehari K, Giroud M, Greenberg SM, Hallevi H, Hemphill JC 3rd, Heuschmann P, Juvela S, Kimura K, Myint PK, Nagakane Y, Naritomi H, Passero S, Rodriguez-Yanez MR, Roquer J, Rosand J, Rost NS, Saloheimo P, Salomaa V, Sivenius J, Sorimachi T, Togha M, Toyoda K, Turaj W, Vemmos KN, Wolfe CD, Woo D, Smith EE: Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 2010;75:1333–1342.
- Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S, Padilla-Martinez JJ, Gonzalez-Cornejo S: Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke 2007;38:1641–1644.
- Wada R, Aviv RI, Fox AJ, Sahlas DJ, Gladstone DJ, Tomlinson G, Symons SP: CT angiography ‘spot sign’ predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 2007;38:1257–1262.
- De Deyn PP, Reuck JD, Deberdt W, Vlietinck R, Orgogozo JM: Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) group. Stroke 1997;28:2347–2352.
- Govan L, Langhorne P, Weir CJ: Categorizing stroke prognosis using different stroke scales. Stroke 2009;40:3396–3399.
- Sulter G, Steen C, De Keyser J: Use of the Barthel Index and modified Rankin Scale in acute stroke trials. Stroke 1999;30:1538–1541.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.